Elekta Announces the Next Generation of Elekta Synergy(R) With 510k Clearance of New Workflow Tools For 4D Adaptive IGRT
Posted on: Thursday, 18 August 2005, 09:00 CDT
Elekta Announces the Next Generation of Elekta Synergy(R) With 510k Clearance of New Workflow Tools For 4D Adaptive IGRT
STOCKHOLM, Sweden, Aug. 18, 2005 (PRIMEZONE) -- Elekta Synergy(R), Elekta's digital linear accelerator used in oncology centers worldwide in the fight against cancer, is once again inspiring clinical confidence in Image Guided Radiation Therapy (IGRT). Significant advancements in cone-beam image quality and almost instantaneous reconstruction of large volumetric images indicate Elekta's 4D Adaptive(TM) IGRT realistically fits into normal, everyday radiation oncology treatment times.
"We promised our customers a healthy upgrade path and with our new suite of enhanced workflow software tools we already are living up to that promise," states Anthony DeCarolis, CEO of Elekta, Inc. and head of Elekta's operations in North America. "Elekta Synergy has proven to be the success story we all hoped it would be. With more than 4,000 clinical images from 20 installations, and more than 50 scheduled to be installed within the next few months, we are confident that this is just the beginning."
Only Elekta gives you the power to apply routinely all three IGRT imaging modes to address complex inter and intra-fraction motion in a seamlessly integrated platform -- Elekta Synergy:
-- PlanarView(TM) -- allows quick orthogonal snapshots of patient anatomy with exceptional image quality due to the use of KV imaging instead of MV portal imaging
-- MotionView(TM) -- fluoroscopic-like, real-time monitoring of high contrast tumors or internal organs in order to accurately characterize internal motion at the time of treatment
-- VolumeView(TM) -- very high-resolution volumetric images with more than 25cm of anatomy visible in the cranial / caudel direction for highly precise 3-dimensional anatomic alignment. Up to a 48cm field of view is available with tremendous patient clearance allowing imaging without moving the patient out of the treatment position.
"We are really proud of what we've achieved with Elekta Synergy," says Jill Stief, Senior Product Manager - IGRT Solutions, from Elekta. "Not only is it still the only commercially available clinically-developed IGRT solution comprising high resolution 3D imaging with a full suite of matching, registration and repositioning tools -- it is also the only system which has been designed for IGRT from the ground up".
For further information, please contact:
International:
Peter Ejemyr Group VP Corporate Communications, Elekta AB +46 733 611 000 peter.ejemyr@elekta.com
US: Lars Jonsteg VP Investor Relations North America, Elekta, USA +46 708 78 37 35 lars.jonsteg@elekta.com
About Elekta
Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta's solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.
Clinical solutions include among others Leksell Gamma Knife(R) for non-invasive treatment of brain surgery and Elekta Synergy(R) for image guided radiation therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, The Elekta Group is the world's largest supplier of oncology software.
Elekta's systems and solutions are used at over 3,000 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders.
With approx. 1700 employees, Elekta's corporate headquarter is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb.
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download:
http://wpy.waymaker.net/client/waymaker1/WOLReleaseFile.aspx?id=122706&fn=wkr0001.pdf
PDF Version
-0-
Copyright © 2005 PrimeZone Media Network, Inc.
Source: PrimeZone Media Network
Related Articles
- Wii Gaming System Could Offer Radiologists an Alternative Way to View Patient Images
- Frost & Sullivan Recognizes Nanopoint for its Pioneering Cell Imaging Solution, the cellTRAY(R) Imaging System CT-2000
- Molecular Imaging Enables Earlier, Individualized Treatment Of Thyroid Cancer
- AngioChem's ANG1005 Demonstrates Preliminary Clinical Safety and Tolerability in Brain Cancer Patients
- Elekta Launches Web-Based Virtual Clinic, Offers Better Understanding of Radiotherapy Solutions for the Treatment of Cancer
- Timothy R. Wright Appointed President of Tyco Healthcare's Pharmaceutical Products and Imaging Solutions Units
- Avantogen and Innovate Oncology Announce Presentation of Clinical Data Demonstrating Extended Survival in Patients With Pancreatic Cancer Treated With RP101
- NeoRx Announces Treatment of First Patient With Picoplatin in Phase 2 Clinical Trial in Small Cell Lung Cancer
- Australian Cancer Technology Reports Doubling of Mean Survival Time in Patients With Pancreatic Cancer Using RP101 With Chemotherapy Treatment
- Palliative Treatment of Painful Disseminated Bone Metastases With ^Sup 186^Rhenium-HEDP in Patients With Lung Cancer
 |
 |
User Comments (0)
RSS Feeds